Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study.
Frippiat F, Musuamba FT, Seidel L, Albert A, Denooz R, Charlier C, Van Bambeke F, Wallemacq P, Descy J, Lambermont B, Layios N, Damas P, Moutschen M.
Frippiat F, et al. Among authors: charlier c.
J Antimicrob Chemother. 2015 Jan;70(1):207-16. doi: 10.1093/jac/dku354. Epub 2014 Sep 12.
J Antimicrob Chemother. 2015.
PMID: 25216821